Clinical Research On PBC Patients By Treatment Of Promoting Blood Circulation For Removing Blood Stasis And Dispersing Stagnated Liver Qi For Promoting Bile Flow And Giving UDCA

Background:Primary biliary cirrhosis (PBC) is one of the common diseases of Europe and the United States and other developed countries, the past incidence is relatively low in China, but research shows that China’s incidence rate showed an increasing trend, the patients with more than90%35-65year-old female, male and female incidence ratio of1:10, there is significant familial aggregation tendency, visible clinical signs of autoantibodies, elevated immunoglobulin combined immune system diseases, the etiology and pathogenesis of this disease is not clear, the treatment can not betreatment for the cause is still symptomatic and supportive therapy, yet the lack of specific therapy ways, the treatment of promoting blood circulation for removing blood stasis and dispersing stagnated liver qi for promoting bile flow, based on years of clinical experience of the National Medical master Professor Zhou Zhongying the treatment of chronic liver disease, starting from the theory of damp-heat and blood-stasis-toxin characterized by the chronic liver dieases, Clearing damp-heat and blood-stasis-toxin and dispersing stagnated liver qi totally played the achievements of promoting bile flow. On this basis, the use of the Clinical dialectical addition and subtraction, care is to achieve the banishment of evil spirits, evil to positive safety efficacy.Objective:through clinical trials to observe the clinical efficacy treatment of promoting blood circulation for removing blood stasis and dispersing stagnated liver qi for promoting bile flow combined with UDCA treatment of primary biliary cirrhosis, the clinical treatment of this disease provide a valid prescription.Methods:30cases of PBC patients met the inclusion criteria, treatment combinations were randomly divided into control group, main square of the Chinese medicine combined with ursodeoxycholic acid (UDCA) treatment in the control group to the UDCA treatment, treatment for six months, two groups of patients with symptoms and signs, liver function, blood coagulation and other indicators of change in the record before and after treatment, using SPSS13.0for statistical analysis, comparative analysis of efficacy evaluation treatment of promoting blood circulation for removing blood stasis and purging liver and gallbladder with dispersing stagnated liver qi for promoting bile flow is the clinical efficacy of the law.Result:The treatment group significantly improved the clinical symptoms and signs of patients with fatigue, hypochondriac pain, jaundice, skin itching, role of ALT、ALP、TBil and GGT and other liver function indicators improved significantly in improving the blood coagulation, liver fibrosisthan the control group has obvious advantages. Conclusion:treatment of promoting blood circulation for removing blood stasis and dispersing stagnated liver qi for promoting bile flow, the clinical efficacy of the treatment of PBC significantly, is worth further study.